Alessandro Piergentili

12PUBLICATIONS
26CO-AUTHORS
Biologically active moleculesGlycoconjugatesClinical pharmacology and therapeuticsCharacterisation of biological macromoleculesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 29, 2025
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma.

Federica Matteucci, Pegi Pavletić, Alessandro Bonifazi

|Jun 04, 2024
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma.

Maria Beatrice Morelli, Miriam Caviglia, Carlo Santini

|Apr 10, 2023
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.

Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni

|Sep 13, 2022
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Pegi Pavletić, Ana Semeano, Hideaki Yano

|Mar 14, 2022
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects.

Fabio Del Bello, Maura Pellei, Luca Bagnarelli

|Feb 14, 2022
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.

Gianfabio Giorgioni, Fabio Del Bello, Wilma Quaglia

Pageof 2

Frequent Collaborators

11 joint publications

Gianfabio Giorgioni

11 joint publications

Wilma Quaglia

10 joint publications

Fabio Del Bello

7 joint publications

Giulio Vistoli